Hubertus von Baumbach (#607)
- $ 7 B
- Pharma
- Germany
- M
- 58 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Hubertus von Baumbach is the chairman of Boehringer Ingelheim, the world's largest private pharmaceutical company, headquartered in Germany. Founded in 1885 by Albert Boehringer, the company supplied ingredients to pharmacies, textile merchants and the food industry, and grew to a workforce of 1,500 by 1939. In 1917 the company opened a research department with chemist Heinrich Wieland, Boehringer's cousin, who went on to win the Nobel Prize in Chemistry. An heir to the fortune, von Baumbach joined the company in 2001 and became its chairman in 2016. Today, Boehringer Ingelheim's most well-known drugs treat COPD, anti-coagulation and type 2 diabetes; it now employs 53,000 people and has a presence in 130 markets. Von Baumbach along with 14 members of the family own equal parts of the company.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Hubertus von Baumbach’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Hubertus von Baumbach’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $6.6B
(May 4, 2026)
© Iconic Billionaires